Skip to main content
Neuro-Oncology logoLink to Neuro-Oncology
. 2022 Jul 25;24(11):2008. doi: 10.1093/neuonc/noac178

Corrigendum to: TERT promoter C228T mutation in neural progenitors confers growth advantage following telomere shortening in vivo

PMCID: PMC9629450  PMID: 35876482

This is a corrigendum to: Shunichiro Miki, Tomoyuki Koga, Andrew M Mckinney, Alison D Parisian, Takahiro Tadokoro, Raghavendra Vadla, Martin Marsala, Robert F Hevner, Joseph F Costello, Frank Furnari, TERT promoter C228T mutation in neural progenitors confers growth advantage following telomere shortening in vivo, Neuro-Oncology, 2022, noac080, https://doi.org/10.1093/neuonc/noac080

In the originally published version of this manuscript, the surname of author Martin Marsala was misspelled as Masala.

This error has been corrected.


Articles from Neuro-Oncology are provided here courtesy of Society for Neuro-Oncology and Oxford University Press

RESOURCES